Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: A trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer

Frances A. Shepherd, Giuseppe Giaccone, Lesley Seymour, Channa Debruyne, Andrea Bezjak, Vera Hirsh, Michael Smylie, Sheldon Rubin, Heidi Martins, Alan Lamont, Maciej Krzakowski, Anna Sadura, Benny Zee

Research output: Contribution to journalArticlepeer-review

246 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: A trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences